Demonstration of the retention of 64Cu-ATSM in cardiac myocytes using a novel incubation chamber for screening hypoxia-dependent radiotracers

Nuclear Medicine Communications

Volumn 34, Issue 10, 2013, Pages 1015-1022

  Handley, Maxwell G ^a   Medina, Rodolfo A ^a   Paul, Rowena L ^a   Blower, Philip J ^a   Southworth, Richard ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

64Cu ATSM; cardiac myocytes; hypoxia; incubation chamber; subcellular fractionation

Indexed keywords

COPPER 64; DIACETYL BIS (N4 METHYLTHIOSEMICARBAZONE) CU 64; RADIOPHARMACEUTICAL AGENT; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL HYPOXIA; CELL ISOLATION; CELL SUSPENSION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GAS EXCHANGE; HEART MUSCLE CELL; INTRACELLULAR SPACE; MALE; NONHUMAN; OXYGEN SATURATION; OXYGEN TENSION; RADIOACTIVITY; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CELL HYPOXIA; CELL SURVIVAL; COPPER RADIOISOTOPES; CULTURE MEDIA; HEART VENTRICLES; INTRACELLULAR SPACE; MALE; MYOCYTES, CARDIAC; ORGANOMETALLIC COMPOUNDS; OXYGEN; RADIOACTIVE TRACERS; RATS; RATS, WISTAR; TEMPERATURE; THIOSEMICARBAZONES;

EID: 84883654815     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328363f25e     Document Type: Article

References (31)

1. Kimura C, Oike M, Ito Y. Hypoxia-induced alterations in Ca(2 +) mobilization in brain microvascular endothelial cells. Am J Physiol Heart Circ Physiol 2000; 279:H2310-H2318.
2. Dearling JL, Lewis JS, Mullen G.E., Rae MT, Zweit J, Blower PJ Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro. Eur J Nucl Med Mol Imaging 1998; 25:788-792. (Pubitemid 28377043)
3. Pitts KR, Derry JM, Kerkof K, Lawrence W.A., Toombs CF Differentially regulated functional gene clusters identified during ischemia and reperfusion in isolated cardiac myocytes using coverslip hypoxia. J Pharmacol Toxicol Methods 2008; 57:42-51. (Pubitemid 350137786)
4. Pitts KR, Toombs CF Coverslip hypoxia: a novel method for studying cardiac myocyte hypoxia and ischemia in vitro. Am J Physiol Heart Circ Physiol 2004; 287:H1801-H1812. (Pubitemid 39313289)
5. Pitts KR, Toombs CF Studying ischemia and reperfusion in isolated neonatal rat ventricular myocytes using coverslip hypoxia. Methods Mol Med 2007; 139:271-281.
6. Koch CJ. A thin-film culturing technique allowing rapid gas-liquid equilibration (6 sec) with no toxicity to mammalian cells. Radiat Res 1984; 97:434-442.
7. Martin GV, Cerqueira MD, Caldwell J.H., Rasey JS, Embree L, Krohn KA Fluoromisonidazole. A metabolic marker of myocyte hypoxia. Circ Res 1990; 67:240-244. (Pubitemid 20223746)
8. Biskupiak JE, Grierson JR, Rasey J.S., Martin GV, Krohn KA Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging. J Med Chem 1991; 34:2165-2168.
9. Dearling JL, Lewis JS, Mullen G.E., Rae MT, Zweit J, Blower PJ Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro. Eur J Nucl Med 1998; 25:788-792. (Pubitemid 28377043)
10. Dearling JL, Lewis JS, Mullen G.E., Welch MJ, Blower PJ Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships. J Biol Inorg Chem 2002; 7:249-259. (Pubitemid 36056377)
11. Dearling JLJ, Lewis JS, McCarthy D.W., Welch MJ, Blower PJ Redox-active metal complexes for imaging hypoxic tissues: structure-activity relationships in copper(II) bis(thiosemicarbazone) complexes. Chem Commun 1998; 25:2531-2532. (Pubitemid 28528382)
12. 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med 1999; 40:177-183. (Pubitemid 29044189)
13. Burgman P, O'Donoghue JA, Lewis JS, Welch M.J., Humm JL, Ling CC Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM. Nucl Med Biol 2005; 32:623-630. (Pubitemid 40981818)
14. Vavere AL, Lewis JS Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines. Nucl Med Biol 2008; 35:273-279. (Pubitemid 351381965)
15. Weeks AJ, Paul RL, Marsden P.K., Blower PJ, Lloyd DR, et al Radiobiological effects of hypoxia-dependent uptake of Cu-64-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells. Eur J Nucl Med Mol Imaging 2010; 37:330-338.
16. Gingras BA, Suprunchuk T, Bayley CH The preparation of some thiosemicarbazones and their copper complexes: Part III. Can J Chem 1962; 40:1053-1059.
17. Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol 1996; 23: 957-980. (Pubitemid 27050682)
18. Snabaitis AK, Muntendorf A, Wieland T., Avkiran M. Regulation of the extracellular signal-regulated kinase pathway in adult myocardium: differential roles of Gq/11, Gi and G12/13 proteins in signalling by [alpha] 1-adrenergic, endothelin-1 and thrombin-sensitive protease-activated receptors. Cell Signal 2005; 17:655-664. (Pubitemid 40430968)
19. Bonow RO, Udelson JE Left ventricular diastolic dysfunction as a cause of congestive heart failure. Ann Intern Med 1992; 117:502-510.
20. Hoenig MR, Bianchi C, Rosenswieg A., Sellke FW The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure. Curr Vasc Pharmacol 2008; 6:292-300.
21. Bekeredjian R, Walton CB, MacCannell K.A., Ecker J., Kruse F, Outten JT, et al Conditional HIF-1a expression produces a reversible cardiomyopathy. PLoS One 2010; 5:e11693.
22. Chung Y. Oxygen reperfusion is limited in the postischemic hypertrophic myocardium. Am J Physiol Heart Circ Physiol 2006; 290:H2075-H2084.
23. Handley MG, Medina RA, Nagel E, Blower P.J., Southworth R. PET imaging of cardiac hypoxia: opportunities and challenges. J Mol Cell Cardiol 2011; 51:640-650.
24. Chen IY, Wu JC Cardiovascular molecular imaging: focus on clinical translation. Circulation 2011; 123:425-443.
25. Sinusas AJ. The potential of myocardial imaging with hypoxia markers. Semin Nucl Med 1999; 29:330-338. (Pubitemid 29487500)
26. Blower PJ, Castle TC, Cowley A.R., Dilworth JR, Donnelly PS, Labisbal E, et al Structural trends in copper(II) bis(thiosemicarbazone) radiopharmaceuticals. Dalton Trans 2003; 23:4416-4425.
27. Blower PJ, Went MJ, Martin K.E., Smith GE Imaging hypoxia in vivo by controlling the electrochemistry of copper radionuclide complexes. J Labelled Comp Radiopharm 2007; 50:354-359. (Pubitemid 47309016)
28. Dearling J, Lewis J, Mullen G., Welch M, Blower P. Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships. J Biol Inorg Chem 2002; 7:249-259. (Pubitemid 36056377)
29. 64Cu-labeled bis(selenosemicarbazone) and bis(thiosemicarbazone) complexes as hypoxia imaging agents. Nucl Med Biol 2005; 32:147-156. (Pubitemid 40260666)
30. Mitchell RH, Bailey AH, Anderson J.M., Gilmore WS Electrical stimulation of cultured myocardial cells. J Biomed Eng 1992; 14:52-56.
31. 64Cu-ATSM as a radiotherapy agent. Nucl Med Biol 2005; 32:21-28. (Pubitemid 40187378)